Using Nanoliposomes to Make Cancer Therapies Safer and More Effective
RARECast - Un pódcast de RARECast - Jueves
Categorías:
Marc Hedrick, CEO of Plus Therapeutics, discusses the company’s nanoliposome technology, how it works, and why the company is focusing on rare cancers.
